Machine learning and radiomics analysis by computed tomography in colorectal liver metastases patients for RAS mutational status prediction-Reference-Cited by-同舟云学术

Machine learning and radiomics analysis by computed tomography in colorectal liver metastases patients for RAS mutational status prediction

Published:2024-05-18 Issue:7 Volume:129 Page:957-966
ISSN:1826-6983
Container-title:La radiologia medica
language:en
Short-container-title:Radiol med

Author:

Granata Vincenza^ORCID,Fusco Roberta,Setola Sergio Venanzio,Brunese Maria Chiara,Di Mauro Annabella,Avallone Antonio,Ottaiano Alessandro,Normanno Nicola,Petrillo Antonella,Izzo Francesco

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11547-024-01828-5.pdf

Reference38 articles.

1. Ottaiano A, Scala S, Santorsola M, Trotta AM, D’Alterio C, Portella L, Clemente O, Nappi A, Zanaletti N, De Stefano A, Avallone A, Granata V, Notariello C, Luce A, Lombardi A, Picone C, Petrillo A, Perri F, Tatangelo F, Di Mauro A, Albino V, Izzo F, Rega D, Pace U, Di Marzo M, Chiodini P, De Feo G, Del Prete P, Botti G, Delrio P, Caraglia M, Nasti G (2021) Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol. Ther Adv Med Oncol 24(13):1758835921989223. https://doi.org/10.1177/1758835921989223

2. Ottaiano A, Caraglia M, Di Mauro A, Botti G, Lombardi A, Galon J, Luce A, D’Amore L, Perri F, Santorsola M, Hermitte F, Savarese G, Tatangelo F, Granata V, Izzo F, Belli A, Scala S, Delrio P, Circelli L, Nasti G (2020) Evolution of mutational landscape and tumor immune-microenvironment in liver oligo-metastatic colorectal cancer. Cancers (Basel) 12(10):3073. https://doi.org/10.3390/cancers12103073

3. Cervantes A, Adam R, Roselló S, Arnold D, Normanno N, Taïeb J, Seligmann J, De Baere T, Osterlund P, Yoshino T, Martinelli E, ESMO Guidelines Committee (2023) Electronic address: clinicalguidelines@esmo.org. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 34(1):10–32. https://doi.org/10.1016/j.annonc.2022.10.003

4. Mateo J, Steuten L, Aftimos P, André F, Davies M, Garralda E, Geissler J, Husereau D, Martinez-Lopez I, Normanno N, Reis-Filho JS, Stefani S, Thomas DM, Westphalen CB, Voest E (2022) Delivering precision oncology to patients with cancer. Nat Med 28(4):658–665. https://doi.org/10.1038/s41591-022-01717-2

5. Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bièche I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, André F (2020) Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group. Ann Oncol 31(11):1491–1505. https://doi.org/10.1016/j.annonc.2020.07.014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Lymph Node Metastasis in Endometrial Cancer Based on Color Doppler Ultrasound Radiomics;Academic Radiology;2024-09